Jeff Yass’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Buy
87,200
+10,200
+13% +$135K ﹤0.01% 7565
2026
Q1
$1.06M Buy
77,000
+14,700
+24% +$222K ﹤0.01% 7739
2025
Q4
$1.12M Sell
62,300
-4,100
-6% -$73.6K ﹤0.01% 6920
2025
Q3
$1.23M Buy
66,400
+47,800
+257% +$751K ﹤0.01% 6853
2025
Q2
$298K Sell
18,600
-15,200
-45% -$271K ﹤0.01% 10358
2025
Q1
$657K Sell
33,800
-13,800
-29% -$290K ﹤0.01% 8300
2024
Q4
$1.05M Sell
47,600
-45,700
-49% -$880K ﹤0.01% 6831
2024
Q3
$1.57M Buy
93,300
+64,600
+225% +$959K ﹤0.01% 5798
2024
Q2
$343K Buy
+28,700
New +$321K ﹤0.01% 9152
2023
Q4
Sell
-20,000
Closed -$153K 12437
2023
Q3
$153K Sell
20,000
-59,300
-75% -$445K ﹤0.01% 10529
2023
Q2
$571K Sell
79,300
-11,500
-13% -$67K ﹤0.01% 7994
2023
Q1
$553K Buy
90,800
+22,700
+33% +$123K ﹤0.01% 8326
2022
Q4
$297K Buy
68,100
+1,300
+2% +$5.81K ﹤0.01% 9126
2022
Q3
$262K Buy
66,800
+8,100
+14% +$40.6K ﹤0.01% 10135
2022
Q2
$299K Buy
58,700
+47,700
+434% +$248K ﹤0.01% 9571
2022
Q1
$70K Buy
+11,000
New +$72.9K ﹤0.01% 12128
2021
Q4
Sell
-35,800
Closed -$332K 13170
2021
Q3
$332K Buy
+35,800
New +$374K ﹤0.01% 10355

Other funds holding CLBT

Jeff Yass's CLBT Position: Q2 2026 in Review

Jeff Yass reduced its Cellebrite (CLBT) stake by 50% in Q2 2026, selling an estimated $675K and leaving 50,564 shares worth $738K. The position accounts for ﹤0.01% of the portfolio, ranked #8976.

Jeff Yass first reported a position in CLBT in Q4 2021 and has held it in 17 quarters since. The position peaked at $5.13M in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Jeff Yass held 50,564 shares of Cellebrite worth $738K as of Q2 2026.
  • Jeff Yass sold 51,052 Cellebrite shares in Q2 2026, an estimated $675K.
  • Cellebrite made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8976 holding.
  • Jeff Yass first reported a position in Cellebrite in Q4 2021 and has held it in 17 quarters since.
  • Jeff Yass's Cellebrite position peaked at $5.13M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.